The results showed that the expression of ANT3 and PINK1 in the bone marrow biopsy specimens of MM patients was significantly higher than that in the control specimens (Figure 7G), indicating that detecting the levels of ANT3 and mitophagy is of great significance for guiding MM clinical treatment strategy, especially in relapsed and drug-resistant MM patients. The gene discussed is SLC25A6; the disease is Miyoshi myopathy.